NCT05242237View on ClinicalTrials.gov

Prognostic Value of Liver Cancer CTCs Isolated by a Novel Microfluidic Platform

UnknownOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

December 1, 2021

Primary Completion Date

January 31, 2024

Study Completion Date

January 31, 2024

Conditions
Hepatocellular CarcinomaCirculating Tumor CellWhole Genome Sequencing
Trial Locations (1)

Unknown

RECRUITING

the second affiliated hospital of Chongqing Medical University, Chongqing

Sponsors
All Listed Sponsors
collaborator

Cellomics International Limited

UNKNOWN

lead

The Second Affiliated Hospital of Chongqing Medical University

OTHER